These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37337149)

  • 1. Regulon analysis identifies protective FXR and CREB5 in proximal tubules in early diabetic kidney disease.
    Shi W; Le W; Tang Q; Shi S; Shi J
    BMC Nephrol; 2023 Jun; 24(1):180. PubMed ID: 37337149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease.
    Zhang X; Chao P; Zhang L; Xu L; Cui X; Wang S; Wusiman M; Jiang H; Lu C
    Front Immunol; 2023; 14():1030198. PubMed ID: 37063851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease.
    Ma Z; Li L; Livingston MJ; Zhang D; Mi Q; Zhang M; Ding HF; Huo Y; Mei C; Dong Z
    J Clin Invest; 2020 Sep; 130(9):5011-5026. PubMed ID: 32804155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Protein Translation and Carboxylic Acid Catabolic Processes in Diabetic Kidney Disease.
    Collins KS; Eadon MT; Cheng YH; Barwinska D; Melo Ferreira R; McCarthy TW; Janosevic D; Syed F; Maier B; El-Achkar TM; Kelly KJ; Phillips CL; Hato T; Sutton TA; Dagher PC
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease.
    Huang F; Wang Q; Guo F; Zhao Y; Ji L; An T; Song Y; Liu Y; He Y; Qin G
    EBioMedicine; 2019 Oct; 48():491-504. PubMed ID: 31629675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Pathobiology of Diabetic Kidney Disease.
    Thomas MC
    Adv Chronic Kidney Dis; 2021 Jul; 28(4):282-289. PubMed ID: 34922684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E1 attenuates high glucose-induced apoptosis in proximal renal tubular cells by inhibiting the JNK/Bim pathway.
    Zhang YH; Zhang YQ; Guo CC; Wang LK; Cui YJ; Dong JJ; Liao L
    Acta Pharmacol Sin; 2020 Apr; 41(4):561-571. PubMed ID: 31685975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model.
    Wang XX; Jiang T; Shen Y; Caldas Y; Miyazaki-Anzai S; Santamaria H; Urbanek C; Solis N; Scherzer P; Lewis L; Gonzalez FJ; Adorini L; Pruzanski M; Kopp JB; Verlander JW; Levi M
    Diabetes; 2010 Nov; 59(11):2916-27. PubMed ID: 20699418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNAs may impact podocytes and proximal tubule function through modulating miRNAs expression in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus patients.
    Petrica L; Hogea E; Gadalean F; Vlad A; Vlad M; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Motoc A; Cretu OM; Radu D; Milas O; Golea-Secara A; Simulescu A; Mogos-Stefan M; Patruica M; Balint L; Ienciu S; Vlad D; Popescu R
    Int J Med Sci; 2021; 18(10):2093-2101. PubMed ID: 33859515
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploring the Role of CircRNA in Diabetic Kidney Disease from a Novel Perspective: Focusing on Both Glomeruli and Tubuli.
    Liu Y; Zhang L; Wang Y; Bai L; Chen S; Yang J; Wang X
    DNA Cell Biol; 2021 Nov; 40(11):1369-1380. PubMed ID: 34767731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
    Jin J; Ye M; Hu K; Gong J; He Q
    Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin β6 mediates epithelial-mesenchymal transition in diabetic kidney disease.
    Li X; Miao Y; Li T; Liu X; Xu L; Guo J; Yu X; Sun B; Zhu Y; Ai D; Chen L
    Mol Cell Endocrinol; 2023 Jul; 572():111955. PubMed ID: 37187284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes derived from mesenchymal stem cells attenuate diabetic kidney disease by inhibiting cell apoptosis and epithelial-to-mesenchymal transition via miR-424-5p.
    Cui C; Zang N; Song J; Guo X; He Q; Hu H; Yang M; Wang Y; Yang J; Zou Y; Gao J; Wang L; Wang C; Liu F; He F; Hou X; Chen L
    FASEB J; 2022 Oct; 36(10):e22517. PubMed ID: 36036527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased secretion and profibrotic activity of tubular exosomes in diabetic kidney disease.
    Wen J; Ma Z; Livingston MJ; Zhang W; Yuan Y; Guo C; Liu Y; Fu P; Dong Z
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F664-F673. PubMed ID: 32715764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Renin in Patients and Mice With Diabetic Kidney Disease.
    Tang J; Wysocki J; Ye M; Vallés PG; Rein J; Shirazi M; Bader M; Gomez RA; Sequeira-Lopez MS; Afkarian M; Batlle D
    Hypertension; 2019 Jul; 74(1):83-94. PubMed ID: 31079532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
    Guo J; Liu Z; Gong R
    Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
    Wang XX; Wang D; Luo Y; Myakala K; Dobrinskikh E; Rosenberg AZ; Levi J; Kopp JB; Field A; Hill A; Lucia S; Qiu L; Jiang T; Peng Y; Orlicky D; Garcia G; Herman-Edelstein M; D'Agati V; Henriksen K; Adorini L; Pruzanski M; Xie C; Krausz KW; Gonzalez FJ; Ranjit S; Dvornikov A; Gratton E; Levi M
    J Am Soc Nephrol; 2018 Jan; 29(1):118-137. PubMed ID: 29089371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming Growth Factor Beta 1 Drives a Switch in Connexin Mediated Cell-to-Cell Communication in Tubular Cells of the Diabetic Kidney.
    Hills C; Price GW; Wall MJ; Kaufmann TJ; Chi-Wai Tang S; Yiu WH; Squires PE
    Cell Physiol Biochem; 2018; 45(6):2369-2388. PubMed ID: 29587265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment effects of soluble guanylate cyclase modulation on diabetic kidney disease at single-cell resolution.
    Balzer MS; Pavkovic M; Frederick J; Abedini A; Freyberger A; Vienenkötter J; Mathar I; Siudak K; Eitner F; Sandner P; Grundmann M; Susztak K
    Cell Rep Med; 2023 Apr; 4(4):100992. PubMed ID: 37023747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy.
    Brezniceanu ML; Lau CJ; Godin N; Chénier I; Duclos A; Ethier J; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    J Am Soc Nephrol; 2010 Jun; 21(6):943-54. PubMed ID: 20299359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.